Testing effectiveness (Phase 2)UnknownNCT04197323
What this trial is testing
Alprostadil Liposomes for Injection for Lower Extremity Arteriosclerosis Obliteran
Who this might be right for
Peripheral Artery Disease
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 20